Holding(s) in Company (5266R)
November 04 2011 - 7:45AM
UK Regulatory
TIDMAGI
RNS Number : 5266R
AGI Therapeutics plc
04 November 2011
AGI Therapeutics plc ('AGI')
Holding in Company
AGI was notified on 2(nd) November 2011 that Paul Johnson has
increased his shareholding to 2,050,615 shares representing 3.04%
of AGI's Issued share capital.
Contact Information
AGI Therapeutics
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUSSARASAARAA
AGI (LSE:AGI)
Historical Stock Chart
From Jan 2025 to Feb 2025
AGI (LSE:AGI)
Historical Stock Chart
From Feb 2024 to Feb 2025
